Hydrochloric Acid

Hydrochloric Acid

SCHEMBL968301

CCCCCCCCCCCCCCCCCC(C)(C)P.Cl

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.44
THRB P10828 1/20 0.44
GGPS1 O95749 6/20 0.39
DNM1 Q05193 3/20 0.39
FDPS P14324 9/20 0.38
SMPD1 P17405 2/20 0.37
CES2 O00748 1/20 0.37
LPAR1 Q92633 1/20 0.37
LPAR3 Q9UBY5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14840465 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL14422028 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL6546949 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL8651140 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL7757197 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL1178287 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL5687998 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL17529752 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL3649144 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1
SCHEMBL27931950 0.97 TSHR (0.47) TSHRTHRBGGPS1FDPSSMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110015442-A1 SULFONE COMPOUND AND METHOD FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-01-20 US disclosed
US-20110015441-A1 SULFONE COMPOUND AND PROCESS FOR PRODUCING CAROTENOID USING THE SAME COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-01-20 US disclosed
EP-1477477-B1 PROCESS FOR PREPARATION OF CAROTENOIDS SUMITOMO CHEMICAL CO (JP) 2010-12-22 EP disclosed
EP-2261204-A1 SULFONE COMPOUND AND METHOD FOR PRODUCING THE SAME Sumitomo Chemical Company, Limited (JP) 2010-12-15 EP disclosed
EP-2253613-A1 SULFONE COMPOUND AND CAROTENOID MANUFACTURING METHOD USING SAID COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-11-24 EP disclosed
US-20080214386-A1 Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-09-04 US disclosed
EP-1477477-A1 PROCESS FOR PREPARATION OF CAROTENOIDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-17 EP disclosed
US-20040204612-A1 Process for preparation of carotenoids SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-10-14 US disclosed
EP-1199303-B1 Process for producing retinol and intermediate compounds for producing the same SUMITOMO CHEMICAL CO (JP) 2004-09-22 EP disclosed
US-6784321-B2 1-((2-ARYLSULFONYL)(3-METHYL)(5-OXY)PENT-3-ENE)-2,6,6-TRIMETHY LCYCLOHEX-1-ENE DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-08-31 US disclosed
EP-1199303-A1 Process for producing retinol and intermediate compounds for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-04-24 EP disclosed
US-6348622-B1 CHEMICAL INTERMEDIATES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-02-19 US disclosed
US-6297402-B1 CHEMICAL INTERMEDIATES FOR ASTAXANTHINE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-10-02 US disclosed
US-20010025127-A1 Dihalo-compound and process for producing vitamin A derivative SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2001-09-27 US disclosed
EP-1120398-A2 Dihalo-compound and process for producing vitamin A derivative SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-08-01 EP disclosed
US-6211411-B1 SULFONE ALDEHYDE DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-04-03 US disclosed
US-6172265-B1 DRUG; FOOD OR FEED ADJUVANT; CHEMICAL INTERMEDIATE FOR CANTHAXANTHIN SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2001-01-09 US disclosed
US-6160181-A Tetraene derivative and process for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-12-12 US disclosed
EP-0983998-A1 Tetraene derivative and process for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-03-08 EP disclosed
EP-0900785-A2 Vitamin A related compounds and process for producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-03-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204612-A1 Process for preparation of carotenoids SCLY, RPS4Y1, ENY2 TSHR 2760/4885THRB 2845/4885GGPS1 2012/4885
US-20110015442-A1 SULFONE COMPOUND AND METHOD FOR PRODUCING THE SAME MSRB3, HCN4, SULT1E1 TSHR 405/4885THRB 3058/4885GGPS1 3755/4885
US-20010025127-A1 Dihalo-compound and process for producing vitamin A derivative CYP2R1, CYP24A1, VDR TSHR 684/4885THRB 1239/4885GGPS1 1669/4885
US-20110015441-A1 SULFONE COMPOUND AND PROCESS FOR PRODUCING CAROTENOID USING THE SAME COMPOUND SCLY, ENY2, ZYX TSHR 2826/4885THRB 3272/4885GGPS1 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.